Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.54 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.49 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.48 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3409877 | 1.00 | MAPT (0.55) | MAPTRXFP1TRPA1S1PR2S1PR4 | |
| SCHEMBL3974022 | 0.98 | MAPT (0.52) | MAPTRXFP1TRPA1S1PR2S1PR4 | |
| SCHEMBL4060725 | 0.85 | CNR2 (0.49) | HDAC1HDAC2HDAC3MAPK1ADRA1A | |
| SCHEMBL29792919 | 0.83 | MAPT (0.60) | MAPTRXFP1TRPA1S1PR2S1PR4 | |
| SCHEMBL11294877 | 0.83 | MAPT (0.60) | MAPTRXFP1TRPA1S1PR2S1PR4 | |
| SCHEMBL11291692 | 0.83 | MAPT (0.60) | MAPTRXFP1TRPA1S1PR2S1PR4 | |
| SCHEMBL7102236 | 0.83 | MAPT (0.60) | MAPTRXFP1TRPA1S1PR2S1PR4 | |
| SCHEMBL28554084 | 0.83 | MAPT (0.60) | MAPTRXFP1TRPA1S1PR2S1PR4 | |
| SCHEMBL11288235 | 0.83 | MAPT (0.60) | MAPTRXFP1TRPA1S1PR2S1PR4 | |
| SCHEMBL5511989 | 0.83 | MAPT (0.60) | MAPTRXFP1TRPA1S1PR2S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024097388-A1 | SYSTEMS AND METHODS FOR MONITORING FATTY ACID METABOLISM | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-05-10 | — | — | WO | claimed |
| WO-2024097388-A1 | SYSTEMS AND METHODS FOR MONITORING FATTY ACID METABOLISM | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-05-10 | — | — | WO | disclosed |
| US-7402405-B2 | Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2008-07-22 | — | — | US | disclosed |
| EP-1404861-A4 | METHODS AND KITS FOR DIAGNOSING A PANCREATIC-BASED FAT MALABSORPTION DISORDER | PHILADELPHIA CHILDREN HOSPITAL (US) | 2006-02-01 | — | — | EP | disclosed |
| EP-1404861-A1 | METHODS AND KITS FOR DIAGNOSING A PANCREATIC-BASED FAT MALABSORPTION DISORDER | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2004-04-07 | — | — | EP | disclosed |
| US-20030086869-A1 | Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 2003-05-08 | — | — | US | disclosed |
| WO-2002099123-A1 | METHODS AND KITS FOR DIAGNOSING A PANCREATIC-BASED FAT MALABSORPTION DISORDER | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2002-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030086869-A1 | Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder | PNLIP, FABP2, FABP6 | MAPT 4747/4885RXFP1 868/4885TRPA1 4832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.